“Production of Lentivirus particles pseudotyped with SARS-CoV-2 spike protein for neutralisation or drug antiviral activity assays” (2023) One Health & Risk Management , p. 77. Available at: https://www.ojs.maxaccs.ie/index.php/journal-ohrm-bba-md/article/view/657 (Accessed: 10 July 2026).